Botulinum toxin injections are the best-established treatment for most forms of focal dystonia, with the highest level of evidence supporting their use. But dystonia isn’t one condition. It varies by which body parts are affected, what’s causing it, and when it started, so the best treatment depends heavily on the type you have. For widespread or generalized dystonia, oral medications and deep brain stimulation play a larger role. Most people benefit from a combination of approaches.
Botulinum Toxin for Focal Dystonia
If dystonia affects one area of your body, such as the neck (cervical dystonia), eyelids (blepharospasm), or hand (writer’s cramp), botulinum toxin injections are the first-line treatment. These injections work by weakening the overactive muscles that cause involuntary contractions. Three formulations are widely used, and all have strong clinical evidence behind them. The American Academy of Neurology gives its highest recommendation (Level A) to three of the four available formulations for cervical dystonia.
The injections typically take effect within about six days and last roughly two to three months before symptoms gradually return. In a 25-year follow-up study of cervical dystonia patients, 96% of injection sessions produced at least moderate improvement, and 78% produced good to excellent results. Only 2% of injections were completely ineffective. Pain relief also carries a Level A recommendation, meaning the evidence for it is strong.
You’ll need repeat injections every three to four months on an ongoing basis. The different formulations perform similarly in overall effectiveness scores, though there are small differences: one tends to last a bit longer per session, while another may offer slightly better pain relief. Your neurologist will typically start with one and adjust based on your response. A small number of people eventually develop antibodies that reduce effectiveness, which is one reason multiple formulations exist.
Oral Medications for Generalized Dystonia
When dystonia affects large areas of the body, injecting individual muscles becomes impractical. Oral medications are the main option here, though none work as reliably as botulinum toxin does for focal types. Finding the right drug often involves trial and error, starting at low doses and increasing gradually.
Anticholinergic drugs are the most commonly used oral treatment for generalized dystonia. They work by blocking a brain chemical involved in muscle control. Doses are increased slowly over weeks because side effects like dry mouth, blurred vision, constipation, and memory problems are common, especially in older adults. Children and younger patients tend to tolerate higher doses better.
A muscle relaxant called baclofen can help reduce muscle stiffness and spasms. It’s started at a very low dose and gradually increased. Sedation and dizziness are the main drawbacks. For some patients with severe generalized dystonia, baclofen can be delivered directly into the spinal fluid through an implanted pump, which reduces the side effects of oral dosing.
Benzodiazepines, a class of anti-anxiety medications, are sometimes added to reduce muscle tension and spasms. They can help, but sedation, impaired coordination, and the risk of dependence limit their long-term usefulness. Doctors typically reserve them as add-on therapy rather than a primary treatment.
The Levodopa Trial
One specific form of childhood-onset dystonia responds dramatically to a dopamine-boosting medication. This condition, sometimes called dopa-responsive dystonia or Segawa syndrome, can be nearly eliminated with low doses of levodopa. Because the response is so striking and the treatment so simple, every child with unexplained dystonia should receive a trial of levodopa for at least three months. Children with this form often respond to very low doses, though some need higher amounts. Adults with unexplained dystonia may also benefit from a trial.
Deep Brain Stimulation
Deep brain stimulation (DBS) is the primary surgical treatment for dystonia that doesn’t respond adequately to medications or injections. It involves implanting thin electrodes into specific targets deep in the brain, connected to a small battery-powered device under the skin near the collarbone. The device sends continuous electrical pulses that interrupt the abnormal brain signals causing dystonia.
The most common brain target is a structure called the GPi, which has been the standard choice for years. Two large double-blind studies found that DBS at this target improved dystonia movement scores by 42% to 51% in generalized and segmental dystonia. More recently, a different target (the STN) has shown promising results, with one study reporting 64% improvement compared to 48% for the traditional target at 12 months.
DBS tends to work best in people with inherited generalized dystonia, particularly those with a specific genetic mutation (DYT1). Improvement is often gradual, taking weeks to months to reach full effect, which differs from DBS for conditions like Parkinson’s disease where benefits can be more immediate. For cervical dystonia specifically, one prospective study found a 43% improvement in movement scores and a 64% improvement in disability scores.
DBS is reversible and adjustable, which is a significant advantage. Settings can be fine-tuned over time, and the device can be turned off or removed if needed. It’s generally considered when botulinum toxin and oral medications haven’t provided adequate relief.
Selective Peripheral Denervation
For cervical dystonia that stops responding to botulinum toxin, a surgical procedure called selective peripheral denervation is an option. This involves cutting specific nerve branches that supply the overactive neck muscles, permanently reducing their ability to contract.
A large single-center study of 160 patients with injection-resistant cervical dystonia found that symptoms improved by 73.5% at three months and maintained a 61.3% improvement at last follow-up. Over half of patients reported meaningful pain relief and improved head posture. Recurrence was low at 4.2%, and complications were minimal. Some patients needed a revision surgery, which delayed improvement but ultimately increased the chance of a good outcome.
Physical Rehabilitation
Physical therapy plays a supporting role in dystonia management, though it rarely provides sufficient relief on its own. For cervical dystonia, rehabilitation typically focuses on stretching and relaxing the overactive muscles while strengthening the opposing muscles that have become weak from disuse. The results of this approach alone are modest.
Newer rehabilitation strategies go beyond the affected body part. Research suggests that adding exercises for postural control, balance reactions, and walking can meaningfully improve daily function. Sensorimotor retraining, which involves exercises designed to recalibrate how your brain processes movement and touch signals, is a growing area of interest. For focal hand dystonia, retraining programs that gradually reintroduce specific movements have shown benefit in some patients. Physical therapy is most effective when combined with botulinum toxin injections or medications rather than used as a standalone treatment.
Cannabis and Unproven Therapies
Cannabis products are frequently discussed as potential treatments for dystonia, but the evidence is weak. A synthetic THC preparation tested in cervical dystonia patients showed no improvement on standard rating scales. CBD showed 20% to 50% improvement in a handful of patients in one small study, but higher doses worsened symptoms in some. The literature on cannabis for dystonia consists almost entirely of case reports and surveys rather than controlled trials, making it impossible to recommend based on current evidence.
MRI-Guided Focused Ultrasound
A newer, incisionless technique uses focused ultrasound waves guided by MRI to precisely destroy tiny areas of brain tissue involved in dystonia. Unlike DBS, it requires no implanted hardware and no incision. Early results look promising, particularly for focal hand dystonia. In one small case series, four out of five patients with focal hand dystonia returned to work within a year of treatment. Improvements have also been seen in dystonia-related tremor and chronic pain.
The catch is that only 18 patients have been treated in published studies so far, all in small case series. The long-term durability of the results is unknown, and unlike DBS, the brain changes are permanent and can’t be reversed or adjusted. This technique is not yet a standard option but is worth watching as larger studies are completed.
Matching Treatment to Dystonia Type
The most important factor in choosing treatment is the distribution of your dystonia. Focal dystonia affecting one body region is best managed with botulinum toxin injections as the starting point, with physical therapy as a complement. Generalized dystonia, especially in children, calls for an initial levodopa trial followed by anticholinergic medications, with DBS considered if medications fall short. Cervical dystonia that becomes resistant to injections has the additional options of selective denervation surgery or DBS.
Age matters too. Children tolerate anticholinergic medications at higher doses than adults and are more likely to have a genetic form that responds well to DBS. Older adults are more prone to the cognitive side effects of anticholinergics and may benefit more from targeted approaches like injections or surgery. Most people with dystonia end up using a combination of treatments, adjusting over time as their symptoms and response evolve.